-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Mjo9NG3cvwgbtEuh99p2ucmC5znWhQIaYmMyaBqt0g3FhHAU9jjKAvi5cWbuwPG9 mfqCYIjQf9N2SkIunHi/Hg== 0000910680-04-000187.txt : 20040212 0000910680-04-000187.hdr.sgml : 20040212 20040212164818 ACCESSION NUMBER: 0000910680-04-000187 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040212 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BENTLEY PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000821616 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 591513162 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-40113 FILM NUMBER: 04592332 BUSINESS ADDRESS: STREET 1: BENTLEY PARK STREET 2: 2 HOLLAND WAY CITY: EXETER STATE: NH ZIP: 03833 BUSINESS PHONE: 6036586100 MAIL ADDRESS: STREET 1: BENTLEY PARK STREET 2: 2 HOLLAND WAY CITY: EXETER STATE: NH ZIP: 03833 FORMER COMPANY: FORMER CONFORMED NAME: BELMAC CORP /FL/ DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MURPHY JAMES R CENTRAL INDEX KEY: 0001218893 FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: BENTLEY PARK STREET 2: 2 HOLLAND WAY CITY: EXETER STATE: NH ZIP: 03833 SC 13G/A 1 sc13ga123103.txt SCHEDULE 13G/A (AMENDMENT NO. 1) ---------------------------- OMB APPROVAL ---------------------------- OMB Number: 3235-0145 ---------------------------- Expires: December 31, 2005 ---------------------------- Estimated average burden hours per response. . . 11 ---------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (AMENDMENT NO. 1) UNDER THE SECURITIES EXCHANGE ACT OF 1934 Bentley Pharmaceuticals, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, par value $.02 per share - -------------------------------------------------------------------------------- (Title of Class of Securities) 082657 10 7 - -------------------------------------------------------------------------------- (CUSIP Number) December 31, 2003 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 082657 10 7 13G/A Page 2 of 5 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON I.R.S. Identification Nos. of above person James R. Murphy - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER NUMBER OF 1,031,963 SHARES ------------------------------------------------------------- BENEFICIALLY OWNED BY 6 SHARED VOTING POWER EACH 0 REPORTING ------------------------------------------------------------- PERSON 7 SOLE DISPOSITIVE POWER WITH 1,031,963 ------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 0 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,031,963 - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.8% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT CUSIP No. 082657 10 7 13G/A Page 3 of 5 Pages - -------------------------------------------------------------------------------- Item 1(a) NAME OF ISSUER: Bentley Pharmaceuticals, Inc. Item 1(b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: Bentley Park 2 Holland Way Exeter, NH 03833 Item 2(a) NAME OF PERSON FILING: James R. Murphy Item 2(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: Bentley Park 2 Holland Way Exeter, NH 03833 Item 2(c) CITIZENSHIP: United States Item 2(d) TITLE OF CLASS OF SECURITIES: Common Stock, par value $.02 Item 2(e) CUSIP NUMBER: 082657 10 7 Item 3 IF THIS STATEMENT IS FILED PURSUANT TO 240.13d-1(b) or 240.13d-2(b) or (c): Not applicable. Item 4 OWNERSHIP: (a) Amount Beneficially Owned: 1,031,963 shares* (b) Percent of Class: 4.8% (c) Number of shares as to which the person has: i. sole power to vote or to direct the vote: 1,031,963 shares* CUSIP No. 082657 10 7 13G/A Page 4 of 5 Pages - -------------------------------------------------------------------------------- ii. shared power to vote or direct the vote: 0 iii. sole power to dispose or to direct the disposition of: 1,031,963 shares* iv. shared power to dispose or to direct the disposition of: 0 * includes 700 shares owned by Reporting Person's sons, as to which Reporting Person disclaims beneficial ownership; also includes 902,000 shares issuable upon the exercise of options which are exercisable within 60 days but are not currently outstanding Item 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: Not applicable. Item 6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: Not applicable. Item 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: Not applicable. Item 8 IDENTIFICATION AND CLASSIFICATION OF MEMBER OF THE GROUP: Not applicable. Item 9 NOTICE OF DISSOLUTION OF GROUP: Not applicable. Item 10 CERTIFICATION: Not applicable. CUSIP No. 082657 10 7 13G/A Page 5 of 5 Pages - -------------------------------------------------------------------------------- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 12, 2004 ------------------------------------------ Date /S/ JAMES R. MURPHY ------------------------------------------ Signature James R. Murphy ------------------------------------------ Name/Title -----END PRIVACY-ENHANCED MESSAGE-----